When did Kiniksa Pharmaceuticals International, plc report Q1 2025 earnings?

Kiniksa Pharmaceuticals International, plc (KNSA) reported Q1 2025 earnings on April 29, 2025 before market open.

What were Kiniksa Pharmaceuticals International, plc's Q1 2025 revenue and EPS?

Kiniksa Pharmaceuticals International, plc reported revenue of $137.8M and diluted EPS of $0.11 for Q1 2025.

Revenue beat the consensus estimate of $131.9M by $5.9M. EPS beat the consensus estimate of $0.02 by $0.09.

You can read the 10-Q periodic report (0001558370-25-005847) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported April 29, 2025 · Before market open

Revenue estimate$131.9M

EPS estimate$0.02

Jul 28, 2026 (in a month)

Revenue estimate$226.6M

EPS estimate$0.30

Q1 2025$137.8MBeat by $5.9M

Q1 2025$0.11Beat by $0.09

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Kiniksa Pharmaceuticals International, plc report Q1 2025 earnings?: Kiniksa Pharmaceuticals International, plc (KNSA) reported Q1 2025 earnings on April 29, 2025 before market open.
What were Kiniksa Pharmaceuticals International, plc's Q1 2025 revenue and EPS?: Kiniksa Pharmaceuticals International, plc reported revenue of $137.8M and diluted EPS of $0.11 for Q1 2025.
Did Kiniksa Pharmaceuticals International, plc beat estimates in Q1 2025?: Revenue beat the consensus estimate of $131.9M by $5.9M. EPS beat the consensus estimate of $0.02 by $0.09.
Where can I find Kiniksa Pharmaceuticals International, plc's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001558370-25-005847) directly on SEC EDGAR. The filing index links above go to sec.gov.